COMMON STOCK PURCHASE WARRANT Neuralstem, Inc.Neuralstem, Inc. • October 29th, 2018 • Biological products, (no disgnostic substances)
Company FiledOctober 29th, 2018 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after six (6) months following the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Neuralstem, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 29th, 2018 • Neuralstem, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 29th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 25, 2018, between Neuralstem, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STRICTLY CONFIDENTIAL Neuralstem, Inc. 20271 Goldenrod Lane, 2nd Floor Germantown, Maryland 20876 Attn: Jim Scully, Chief Executive OfficerLetter Agreement • October 29th, 2018 • Neuralstem, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 29th, 2018 Company Industry JurisdictionThis letter agreement (this “Agreement”) constitutes the agreement between Neuralstem, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) for purposes of financing during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal appro